In a visit to UB, the lawmakers said cutting indirect cost reimbursement for grants would negatively impact livesaving ...

N.Y., decried the cuts as illegal and rooted in a willful misunderstanding of how medical research is conducted at ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

The impact will be crippling to biomedical research in the U.S., and institutions will immediately face hard choices about ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...

Claiming the cuts are illegal, attorneys general from 22 states, including Rhode Island, on Monday sued the Trump administration, the Department of Health and Human Services, and the National ...

In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...

Of course the effects will vary across research institutions, as institutions differ markedly in their operating models and ...

The National Institutes of Health proposal would limit indirect costs for research projects to 15 percent of grants.

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...